{"nct_id":"NCT01978236","title":"Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites","status":"TERMINATED","status_verified_date":"2018-07","start_date":"2014-04-08","start_date_type":"ACTUAL","primary_completion_date":"2017-04-26","primary_completion_date_type":"ACTUAL","completion_date":"2017-04-26","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}